China’s biotech is redrawing the global pharma map; what India can learn
American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...
Fierce Pharma3d
Breaking down pharma’s fourth-quarter sales boom
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
The Financial Express5d
India’s pharma industry betting big on CDMO opportunity – All you need to know
India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...
Market rallies as pharma, financial sectors lead gains
Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5 ...
Countries, global health groups band together as US aid gaps threaten lives
Governments and global health groups are working to try to fill the most urgent gaps in the fight against diseases such as ...
Eight countries could run out of HIV treatments due to USAID cuts, WHO says
The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...
The Manila Times22h
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...
Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Nifty tops 22,500 as global recovery fuel gains; Bajaj twins climb
Domestic stock indices saw minor gains on Monday, buoyed by receding fears of a US government shutdown and anticipation of the US Federal Reserve's upcoming policy review. The Nifty closed just above ...
Selective buying helped Nifty recover losses, even as global market weakness and foreign fund outflows kept investor sentiment cautious
Benchmark indices end mixed as BSE Sensex closes slightly lower, NSE Nifty edges up; selective buying boosts recovery amid ...